BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38583650)

  • 1. Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms.
    Zhao G; Wang Y; Fan Z; Xiong J; Ertas YN; Ashammakhi N; Wang J; Ma T
    Cancer Lett; 2024 Jun; 591():216860. PubMed ID: 38583650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Updated Review on Implications of Autophagy and Apoptosis in Tumorigenesis: Possible Alterations in Autophagy through Engineered Nanomaterials and Their Importance in Cancer Therapy.
    Ghaznavi H; Shirvaliloo M; Zarebkohan A; Shams Z; Radnia F; Bahmanpour Z; Sargazi S; Saravani R; Shirvalilou S; Shahraki O; Shahraki S; Nazarlou Z; Sheervalilou R
    Mol Pharmacol; 2021 Aug; 100(2):119-143. PubMed ID: 33990406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating autophagy: a strategy for cancer therapy.
    Li JL; Han SL; Fan X
    Chin J Cancer; 2011 Oct; 30(10):655-68. PubMed ID: 21959043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy.
    Paskeh MDA; Entezari M; Clark C; Zabolian A; Ranjbar E; Farahani MV; Saleki H; Sharifzadeh SO; Far FB; Ashrafizadeh M; Samarghandian S; Khan H; Ghavami S; Zarrabi A; Łos MJ
    Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166326. PubMed ID: 34942307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-Death or Pro-Survival: Contrasting Paradigms on Nanomaterial-Induced Autophagy and Exploitations for Cancer Therapy.
    Zhang Y; Zhang L; Gao J; Wen L
    Acc Chem Res; 2019 Nov; 52(11):3164-3176. PubMed ID: 31621285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment.
    Cordani M; Somoza Á
    Cell Mol Life Sci; 2019 Apr; 76(7):1215-1242. PubMed ID: 30483817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibitors of autophagy as novel cancer therapeutic agents.
    Wang C; Hu Q; Shen HM
    Pharmacol Res; 2016 Mar; 105():164-75. PubMed ID: 26826398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems.
    Tavakol S; Ashrafizadeh M; Deng S; Azarian M; Abdoli A; Motavaf M; Poormoghadam D; Khanbabaei H; Afshar EG; Mandegary A; Pardakhty A; Yap CT; Mohammadinejad R; Kumar AP
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31557936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy.
    Yun CW; Jeon J; Go G; Lee JH; Lee SH
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics.
    Yang Y; Liu L; Tian Y; Gu M; Wang Y; Ashrafizadeh M; Reza Aref A; Cañadas I; Klionsky DJ; Goel A; Reiter RJ; Wang Y; Tambuwala M; Zou J
    Cancer Lett; 2024 Apr; 587():216659. PubMed ID: 38367897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Sensitive Polymeric Nanoparticles with Gold(I) Compound Payloads Synergistically Induce Cancer Cell Death through Modulation of Autophagy.
    Lin YX; Gao YJ; Wang Y; Qiao ZY; Fan G; Qiao SL; Zhang RX; Wang L; Wang H
    Mol Pharm; 2015 Aug; 12(8):2869-78. PubMed ID: 26101892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
    Sui X; Chen R; Wang Z; Huang Z; Kong N; Zhang M; Han W; Lou F; Yang J; Zhang Q; Wang X; He C; Pan H
    Cell Death Dis; 2013 Oct; 4(10):e838. PubMed ID: 24113172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy as a mechanism of Apo2L/TRAIL resistance.
    Sharma A; Almasan A
    Cancer Biol Ther; 2018; 19(9):755-762. PubMed ID: 30067424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer cells through autophagy for anticancer therapy.
    Turcotte S; Giaccia AJ
    Curr Opin Cell Biol; 2010 Apr; 22(2):246-51. PubMed ID: 20056398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy Regulators in Cancer.
    Zhang J; Xiang Q; Wu M; Lao YZ; Xian YF; Xu HX; Lin ZX
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
    Gutierrez E; Richardson DR; Jansson PJ
    J Biol Chem; 2014 Nov; 289(48):33568-89. PubMed ID: 25301941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
    Jin KT; Lu ZB; Lv JQ; Zhang JG
    RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.